Your browser doesn't support javascript.
loading
A genetic basis of mitochondrial DNAJA3 in nonalcoholic steatohepatitis-related hepatocellular carcinoma.
Chang, Ching-Wen; Chen, Yu-Syuan; Huang, Chen-Hua; Lin, Chao-Hsiung; Ng, Wailap Victor; Chu, Lichieh Julie; Trépo, Eric; Zucman-Rossi, Jessica; Siao, Kevin; Maher, Jacquelyn J; Chiew, Men Yee; Chou, Chih-Hung; Huang, Hsien-Da; Teo, Wan-Huai; Lee, I-Shan; Lo, Jeng-Fan; Wang, Xin Wei.
Affiliation
  • Chang CW; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Chen YS; Institute of Oral Biology, School of Dentistry, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Huang CH; Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan.
  • Lin CH; Institute of Oral Biology, School of Dentistry, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Ng WV; Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chu LJ; Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Trépo E; Department of Biotechnology and Lab Science in Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Zucman-Rossi J; Department of Biochemistry, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Siao K; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Maher JJ; Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Chiew MY; Department of Otolaryngology - Head & Neck Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan.
  • Chou CH; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, INSERM, Paris, France.
  • Huang HD; Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
  • Teo WH; Laboratory of Experimental Gastroenterology, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.
  • Lee IS; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, INSERM, Paris, France.
  • Lo JF; Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Département d'Oncologie, Paris, France.
  • Wang XW; Department of Medicine, Liver Center, University of California, San Francisco, California, USA.
Hepatology ; 2023 Oct 23.
Article in En | MEDLINE | ID: mdl-37870291
BACKGROUND AND AIMS: NAFLD is the most common form of liver disease worldwide, but only a subset of individuals with NAFLD may progress to NASH. While NASH is an important etiology of HCC, the underlying mechanisms responsible for the conversion of NAFLD to NASH and then to HCC are poorly understood. We aimed to identify genetic risk genes that drive NASH and NASH-related HCC. APPROACH AND RESULTS: We searched genetic alleles among the 24 most significant alleles associated with body fat distribution from a genome-wide association study of 344,369 individuals and validated the top allele in 3 independent cohorts of American and European patients (N=1380) with NAFLD/NASH/HCC. We identified an rs3747579-TT variant significantly associated with NASH-related HCC and demonstrated that rs3747579 is expression quantitative trait loci of a mitochondrial DnaJ Heat Shock Protein Family (Hsp40) Member A3 ( DNAJA3 ). We also found that rs3747579-TT and a previously identified PNPLA3 as a functional variant of NAFLD to have significant additional interactions with NASH/HCC risk. Patients with HCC with rs3747579-TT had a reduced expression of DNAJA3 and had an unfavorable prognosis. Furthermore, mice with hepatocyte-specific Dnaja3 depletion developed NASH-dependent HCC either spontaneously under a normal diet or enhanced by diethylnitrosamine. Dnaja3 -deficient mice developed NASH/HCC characterized by significant mitochondrial dysfunction, which was accompanied by excessive lipid accumulation and inflammatory responses. The molecular features of NASH/HCC in the Dnaja3 -deficient mice were closely associated with human NASH/HCC. CONCLUSIONS: We uncovered a genetic basis of DNAJA3 as a key player of NASH-related HCC.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hepatology Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hepatology Year: 2023 Type: Article Affiliation country: United States